Could Dietary Glutamate Play a Role in Psychiatric Distress?
Diet
Fibromyalgia
Glutamate
Monosodium glutamate
Pain
Psychiatric symptoms
Journal
Neuropsychobiology
ISSN: 1423-0224
Titre abrégé: Neuropsychobiology
Pays: Switzerland
ID NLM: 7512895
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
06
2018
accepted:
18
12
2018
pubmed:
31
1
2019
medline:
13
11
2020
entrez:
31
1
2019
Statut:
ppublish
Résumé
Glutamate is an amino acid that functions as an excitatory neurotransmitter. It has also been associated with somatic and psychiatric distress and is implicated in the pathophysiology of psychiatric disorders such as schizophrenia. Ingestion of dietary glutamate, such as monosodium glutamate (MSG), has been mechanistically linked with greater distress among patients with chronic pain conditions, though findings have been equivocal. Preliminary research suggests that an MSG-restricted diet confers beneficial effects on somatic symptoms and well-being for some individuals with chronic pain conditions. In addition to associations with somatic distress, glutamate has been associated with the onset and progression of psychiatric symptoms. Thus, the role of dietary glutamate in psychiatric distress represents an underdeveloped and potentially important area for future research aimed at clarifying pathophysiological mechanisms and identifying targets for dietary intervention in psychiatric illnesses.
Identifiants
pubmed: 30699435
pii: 000496294
doi: 10.1159/000496294
pmc: PMC6667320
mid: NIHMS1006002
doi:
Substances chimiques
Excitatory Amino Acid Agents
0
Flavoring Agents
0
Glutamates
0
Sodium Glutamate
W81N5U6R6U
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
13-19Subventions
Organisme : NIMH NIH HHS
ID : R01 MH082784
Pays : United States
Informations de copyright
© 2019 S. Karger AG, Basel.
Références
J Physiol Anthropol. 2014 Jul 24;33:22
pubmed: 25060574
Harv Rev Psychiatry. 1996 Jan-Feb;3(5):241-53
pubmed: 9384954
Schizophr Bull. 2009 May;35(3):638-45
pubmed: 18245057
Neuropsychopharmacology. 2005 Sep;30(9):1735-40
pubmed: 15841109
J Nutr. 2000 Apr;130(4S Suppl):915S-20S
pubmed: 10736352
Neurotoxicology. 1994 Fall;15(3):535-44
pubmed: 7854587
Mol Psychiatry. 2004 Nov;9(11):984-97, 979
pubmed: 15278097
Am J Clin Nutr. 2011 Jun;93(6):1328-36
pubmed: 21471280
Neuroimage. 2005 Jun;26(2):642-6
pubmed: 15907322
Nat Rev Drug Discov. 2008 May;7(5):426-37
pubmed: 18425072
Curr Pharm Biotechnol. 2018;19(4):293-307
pubmed: 29929462
Pharmacol Ther. 2011 Dec;132(3):314-32
pubmed: 21963369
Psychoneuroendocrinology. 2004 May;29(4):448-74
pubmed: 14749092
Neuropsychopharmacology. 2009 Nov;34(12):2489-96
pubmed: 19675532
Scand J Pain. 2018 Jul 26;18(3):351-361
pubmed: 29794260
Neuropsychopharmacology. 2007 Dec;32(12):2490-9
pubmed: 17429412
Clin Psychol Rev. 2007 May;27(4):409-24
pubmed: 17222489
Ann N Y Acad Sci. 2015 Mar;1338:38-57
pubmed: 25315318
Schizophr Bull. 2012 Sep;38(5):914-9
pubmed: 22390879
Am J Psychiatry. 1999 Oct;156(10):1646-9
pubmed: 10518181
Neuropsychopharmacology. 2018 Jul;43(8):1706-1711
pubmed: 29728648
Curr Top Behav Neurosci. 2012;12:189-207
pubmed: 22261703
J Neurosci. 1989 Sep;9(9):3040-57
pubmed: 2552039
J Nutr. 2000 Apr;130(4S Suppl):1058S-62S
pubmed: 10736382
J Am Acad Nurse Pract. 2006 Oct;18(10):482-6
pubmed: 16999713
Am J Psychiatry. 1962 Jul;119:61-7
pubmed: 14467063
Arch Gen Psychiatry. 1991 Jul;48(7):618-24
pubmed: 2069492
Cereb Cortex. 2003 Sep;13(9):968-76
pubmed: 12902396
Eur J Pharmacol. 1992 Nov 24;224(1):97-8
pubmed: 1451747
Asia Pac J Clin Nutr. 2008;17 Suppl 1:368-71
pubmed: 18296381
J Pain Res. 2017 Jan 31;10:287-293
pubmed: 28203104
Neuroimage. 2010 Jan 15;49(2):1895-902
pubmed: 19761852
Eur Neuropsychopharmacol. 2014 Oct;24(10):1591-605
pubmed: 25159198
Biol Psychiatry. 2008 Oct 15;64(8):718-26
pubmed: 18602089
Am J Epidemiol. 2000 Jan 15;151(2):164-73
pubmed: 10645819
Psychopharmacology (Berl). 1998 Feb;135(3):213-29
pubmed: 9498724
Rheumatol Int. 2014 Jul;34(7):1011-3
pubmed: 23765203
Expert Rev Neurother. 2016;16(4):415-23
pubmed: 26900907
J Headache Pain. 2013 Jan 24;14:2
pubmed: 23565943
J Neurosci. 1997 Apr 15;17(8):2921-7
pubmed: 9092613
Am J Psychiatry. 2000 Apr;157(4):549-59
pubmed: 10739413
J Clin Med. 2016 Nov 22;5(11):
pubmed: 27879650
Neuroreport. 2003 Dec 2;14(17):2225-8
pubmed: 14625452
J Nutr. 1983 Sep;113(9):1851-60
pubmed: 6886827
Eur J Clin Nutr. 2007 Mar;61(3):304-13
pubmed: 16957679
Biol Psychiatry. 2010 Nov 1;68(9):785-94
pubmed: 20728076
Ann Pharmacother. 2001 Jun;35(6):702-6
pubmed: 11408989
Biol Psychiatry. 2010 Jun 1;67(11):1010-6
pubmed: 20079890
Mol Psychiatry. 2009 Jul;14(7):696-704, 647
pubmed: 18347601
Arch Intern Med. 2003 Nov 10;163(20):2433-45
pubmed: 14609780
Front Psychiatry. 2018 Oct 30;9:537
pubmed: 30425662
Am J Physiol Endocrinol Metab. 2000 Jan;278(1):E83-9
pubmed: 10644540
Cephalalgia. 2004 Sep;24(9):735-9
pubmed: 15315529
Neuropsychopharmacology. 2001 Jul;25(1):72-83
pubmed: 11377920
Lancet Psychiatry. 2015 Mar;2(3):271-4
pubmed: 26359904
J Lipid Res. 2009 Aug;50(8):1521-37
pubmed: 19001666
Cephalalgia. 2009 Apr;29(4):423-9
pubmed: 19170689
Neuroscience. 2003;117(3):697-706
pubmed: 12617973
Arch Gen Psychiatry. 1994 Mar;51(3):199-214
pubmed: 8122957
Br J Pharmacol. 1983 Jun;79(2):565-75
pubmed: 6317114
Cephalalgia. 1995 Apr;15(2):132-5
pubmed: 7641248
Curr Treat Options Psychiatry. 2015 Sep;2(3):271-283
pubmed: 26301176
Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):10-7
pubmed: 22766026
J Psychopharmacol. 2015 Feb;29(2):97-115
pubmed: 25586400
Neuropharmacology. 2012 Jan;62(1):63-77
pubmed: 21827775
Biol Psychiatry. 2013 Jan 1;73(1):24-31
pubmed: 22831979
Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7
pubmed: 12466030
J Neurochem. 1993 May;60(5):1650-7
pubmed: 8097232